Please enable JavaScript to continue using this application.

Compare $ACAD vs $CDNA | Chartloom

Compare

$ACAD vs $CDNA

ACADIA Pharmaceuticals Inc · CareDx Inc

ACAD

ACADIA Pharmaceuticals Inc

CDNA

CareDx Inc

Compare $ACAD vs $CDNA

Comparing ACADIA Pharmaceuticals Inc and CareDx Inc

ACADACADIA Pharmaceuticals Inc

CDNACareDx Inc

ACADACADIA Pharmaceuticals Inc

Market cap

$3.39B

P/E (TTM)

8.99x

Forward P/E (NTM)

23.42x

Forward P/S (NTM)

2.37x

Rev growth (TTM)

48.3%

YTD performance

-24.8%

52W performance

-7.2%

FCF yield

4.3%

CDNACareDx Inc

Market cap

$3.29B

P/E (TTM)

30.64x

Forward P/E (NTM)

57.50x

Forward P/S (NTM)

6.55x

Rev growth (TTM)

34.4%

YTD performance

232.7%

52W performance

330.5%

FCF yield

2.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACAD

CDNA

Detailed metrics comparison

ACAD

ACADIA Pharmaceuticals Inc

CDNA

CareDx Inc

Market Cap

ACAD$3.39B

CDNA$3.29B

Enterprise Value

ACAD$3.00B

CDNA$2.92B

Price

ACAD$19.78

CDNA$63.67

P/E Ratio

ACAD8.99x

CDNA30.64x

P/S Ratio

ACAD2.97x

CDNA7.18x

EV/Sales

ACAD2.64x

CDNA6.36x

EV/EBITDA

ACAD24.70x

CDNA23.24x

P/B Ratio

ACAD2.63x

CDNA8.16x

P/FCF Ratio

ACAD23.26x

CDNA39.14x

EV/FCF

ACAD20.62x

CDNA34.70x

PEG Ratio

ACAD0.13x

CDNA0.31x

Forward P/E (NTM)

ACAD23.42x

CDNA57.50x

Forward P/S (NTM)

ACAD2.37x

CDNA6.55x

Revenue (TTM)

ACAD$1.14B

CDNA$458M

Revenue Growth (YoY)

ACAD48.3%

CDNA34.4%

Forward Rev Growth

ACAD12.6%

CDNA7.0%

Gross Margin (TTM)

ACAD91.1%

CDNA70.6%

Operating Margin (TTM)

ACAD7.6%

CDNA23.6%

EBITDA Margin (TTM)

ACAD8.6%

CDNA27.4%

Net Margin (TTM)

ACAD33.4%

CDNA24.2%

FCF Margin (TTM)

ACAD12.8%

CDNA18.3%

Net Income (TTM)

ACAD$380M

CDNA$111M

FCF (TTM)

ACAD$146M

CDNA$84M

EPS (TTM)

ACAD$2.20

CDNA$2.08

ROE (TTM)

ACAD32.4%

CDNA32.8%

ROA (TTM)

ACAD24.4%

CDNA24.8%

ROIC (TTM)

ACAD32.4%

CDNA32.8%

Cash

ACAD$385M

CDNA$374M

Debt

ACAD$0

CDNA$0

Net Cash/Debt

ACAD$385M

CDNA$374M

Current Ratio (TTM)

ACAD3.39x

CDNA4.58x

Quick Ratio (TTM)

ACAD3.11x

CDNA4.35x

Debt/Equity (TTM)

ACAD0.00x

CDNA0.00x

Debt/Assets (TTM)

ACAD0.0%

CDNA0.0%

Interest Coverage (TTM)

ACADN/A

CDNAN/A

Net Debt/EBITDA (TTM)

ACAD0.00x

CDNA0.00x

Beta

ACAD0.91

CDNA2.58

52W Performance

ACAD-7.2%

CDNA330.5%

YTD Performance

ACAD-24.8%

CDNA232.7%

% from 52W High

ACAD-36.1%

CDNA-12.2%

% from 52W Low

ACAD2.4%

CDNA356.4%

Asset Turnover (TTM)

ACAD0.73x

CDNA1.02x

FCF Yield (TTM)

ACAD4.3%

CDNA2.6%

Earnings Yield (TTM)

ACAD11.2%

CDNA3.4%

Dividend Yield (TTM)

ACADN/A

CDNAN/A

Rule of 40

ACAD61.1

CDNA52.7

EV/GP/RG

ACAD0.09

CDNA0.94

Ticker research

View ACAD research View CDNA research

Metric	ACAD ACADIA Pharmaceuticals Inc	CDNA CareDx Inc
Market & Valuation
Market Cap	$3.39B	$3.29B
Enterprise Value	$3.00B	$2.92B
Price	$19.78	$63.67
P/E Ratio	8.99x	30.64x
P/S Ratio	2.97x	7.18x
EV/Sales	2.64x	6.36x
EV/EBITDA	24.70x	23.24x
P/B Ratio	2.63x	8.16x
P/FCF Ratio	23.26x	39.14x
EV/FCF	20.62x	34.70x
PEG Ratio	0.13x	0.31x
Forward P/E (NTM)	23.42x	57.50x
Forward P/S (NTM)	2.37x	6.55x
Revenue & Growth
Revenue (TTM)	$1.14B	$458M
Revenue Growth (YoY)	48.3%	34.4%
Forward Rev Growth	12.6%	7.0%
Profitability
Gross Margin (TTM)	91.1%	70.6%
Operating Margin (TTM)	7.6%	23.6%
EBITDA Margin (TTM)	8.6%	27.4%
Net Margin (TTM)	33.4%	24.2%
FCF Margin (TTM)	12.8%	18.3%
Net Income (TTM)	$380M	$111M
FCF (TTM)	$146M	$84M
EPS (TTM)	$2.20	$2.08
ROE (TTM)	32.4%	32.8%
ROA (TTM)	24.4%	24.8%
ROIC (TTM)	32.4%	32.8%
Financial Health
Cash	$385M	$374M
Debt	$0	$0
Net Cash/Debt	$385M	$374M
Current Ratio (TTM)	3.39x	4.58x
Quick Ratio (TTM)	3.11x	4.35x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.91	2.58
52W Performance	-7.2%	330.5%
YTD Performance	-24.8%	232.7%
% from 52W High	-36.1%	-12.2%
% from 52W Low	2.4%	356.4%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	1.02x
FCF Yield (TTM)	4.3%	2.6%
Earnings Yield (TTM)	11.2%	3.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	61.1	52.7
EV/GP/RG	0.09	0.94
Ticker research	View ACAD research	View CDNA research

Valuation

P/E Ratio

ACAD

8.99x

CDNA

30.64x

P/S Ratio

ACAD

2.97x

CDNA

7.18x

EV/FCF

ACAD

20.62x

CDNA

34.70x

Growth & revenue

Revenue Growth TTM

ACAD

48.3%

CDNA

34.4%

Forward Revenue Growth

ACAD

12.6%

CDNA

7.0%

Profitability & performance

Gross Margin

ACAD

91.1%

CDNA

70.6%

ROE

CDNA

32.8%

ACAD

32.4%

FCF Yield %

ACAD

4.3%

CDNA

2.6%

52-Week Performance

CDNA

330.5%

ACAD

-7.2%

Detailed metrics comparison

ACAD

ACADIA Pharmaceuticals Inc

CDNA

CareDx Inc

Market Cap

ACAD$3.39B

CDNA$3.29B

Enterprise Value

ACAD$3.00B

CDNA$2.92B

Price

ACAD$19.78

CDNA$63.67

P/E Ratio

ACAD8.99x

CDNA30.64x

P/S Ratio

ACAD2.97x

CDNA7.18x

EV/Sales

ACAD2.64x

CDNA6.36x

EV/EBITDA

ACAD24.70x

CDNA23.24x

P/B Ratio

ACAD2.63x

CDNA8.16x

P/FCF Ratio

ACAD23.26x

CDNA39.14x

EV/FCF

ACAD20.62x

CDNA34.70x

PEG Ratio

ACAD0.13x

CDNA0.31x

Forward P/E (NTM)

ACAD23.42x

CDNA57.50x

Forward P/S (NTM)

ACAD2.37x

CDNA6.55x

Revenue (TTM)

ACAD$1.14B

CDNA$458M

Revenue Growth (YoY)

ACAD48.3%

CDNA34.4%

Forward Rev Growth

ACAD12.6%

CDNA7.0%

Gross Margin (TTM)

ACAD91.1%

CDNA70.6%

Operating Margin (TTM)

ACAD7.6%

CDNA23.6%

EBITDA Margin (TTM)

ACAD8.6%

CDNA27.4%

Net Margin (TTM)

ACAD33.4%

CDNA24.2%

FCF Margin (TTM)

ACAD12.8%

CDNA18.3%

Net Income (TTM)

ACAD$380M

CDNA$111M

FCF (TTM)

ACAD$146M

CDNA$84M

EPS (TTM)

ACAD$2.20

CDNA$2.08

ROE (TTM)

ACAD32.4%

CDNA32.8%

ROA (TTM)

ACAD24.4%

CDNA24.8%

ROIC (TTM)

ACAD32.4%

CDNA32.8%

Cash

ACAD$385M

CDNA$374M

Debt

ACAD$0

CDNA$0

Net Cash/Debt

ACAD$385M

CDNA$374M

Current Ratio (TTM)

ACAD3.39x

CDNA4.58x

Quick Ratio (TTM)

ACAD3.11x

CDNA4.35x

Debt/Equity (TTM)

ACAD0.00x

CDNA0.00x

Debt/Assets (TTM)

ACAD0.0%

CDNA0.0%

Interest Coverage (TTM)

ACADN/A

CDNAN/A

Net Debt/EBITDA (TTM)

ACAD0.00x

CDNA0.00x

Beta

ACAD0.91

CDNA2.58

52W Performance

ACAD-7.2%

CDNA330.5%

YTD Performance

ACAD-24.8%

CDNA232.7%

% from 52W High

ACAD-36.1%

CDNA-12.2%

% from 52W Low

ACAD2.4%

CDNA356.4%

Asset Turnover (TTM)

ACAD0.73x

CDNA1.02x

FCF Yield (TTM)

ACAD4.3%

CDNA2.6%

Earnings Yield (TTM)

ACAD11.2%

CDNA3.4%

Dividend Yield (TTM)

ACADN/A

CDNAN/A

Rule of 40

ACAD61.1

CDNA52.7

EV/GP/RG

ACAD0.09

CDNA0.94

Ticker research

View ACAD research View CDNA research

Metric	ACAD ACADIA Pharmaceuticals Inc	CDNA CareDx Inc
Market & Valuation
Market Cap	$3.39B	$3.29B
Enterprise Value	$3.00B	$2.92B
Price	$19.78	$63.67
P/E Ratio	8.99x	30.64x
P/S Ratio	2.97x	7.18x
EV/Sales	2.64x	6.36x
EV/EBITDA	24.70x	23.24x
P/B Ratio	2.63x	8.16x
P/FCF Ratio	23.26x	39.14x
EV/FCF	20.62x	34.70x
PEG Ratio	0.13x	0.31x
Forward P/E (NTM)	23.42x	57.50x
Forward P/S (NTM)	2.37x	6.55x
Revenue & Growth
Revenue (TTM)	$1.14B	$458M
Revenue Growth (YoY)	48.3%	34.4%
Forward Rev Growth	12.6%	7.0%
Profitability
Gross Margin (TTM)	91.1%	70.6%
Operating Margin (TTM)	7.6%	23.6%
EBITDA Margin (TTM)	8.6%	27.4%
Net Margin (TTM)	33.4%	24.2%
FCF Margin (TTM)	12.8%	18.3%
Net Income (TTM)	$380M	$111M
FCF (TTM)	$146M	$84M
EPS (TTM)	$2.20	$2.08
ROE (TTM)	32.4%	32.8%
ROA (TTM)	24.4%	24.8%
ROIC (TTM)	32.4%	32.8%
Financial Health
Cash	$385M	$374M
Debt	$0	$0
Net Cash/Debt	$385M	$374M
Current Ratio (TTM)	3.39x	4.58x
Quick Ratio (TTM)	3.11x	4.35x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.91	2.58
52W Performance	-7.2%	330.5%
YTD Performance	-24.8%	232.7%
% from 52W High	-36.1%	-12.2%
% from 52W Low	2.4%	356.4%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	1.02x
FCF Yield (TTM)	4.3%	2.6%
Earnings Yield (TTM)	11.2%	3.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	61.1	52.7
EV/GP/RG	0.09	0.94
Ticker research	View ACAD research	View CDNA research